PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug called LY4257496 that delivers radiation directly to cancer cells with a specific protein (GRPR). It is for adults with advanced breast, prostate, colorectal, or endometrial cancer that has spread. The goal is to see if the drug is safe and can shrink …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 00:39 UTC
-
Could stronger radiation blast prostate cancer without more side effects?
Disease control Recruiting nowThis study is testing whether giving a higher dose of radiation directly to the prostate (called HDR brachytherapy) can better control early-stage prostate cancer. About 36 men with low- or favorable intermediate-risk prostate cancer will receive one of three dose levels. Researc…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New MRI software aims to sharpen prostate cancer detection
Diagnosis Recruiting nowThis study tests a computer program developed at the University of Chicago that creates risk maps from MRI scans of the prostate. The goal is to see if this tool helps doctors decide where to biopsy more accurately than current methods. About 180 adults with known or suspected pr…
Matched conditions: PROSTATE NEOPLASM
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Apr 30, 2026 15:48 UTC
-
Hot flash hope: new drug tested for men on prostate cancer therapy
Symptom relief Recruiting nowThis study tests if fezolinetant, a drug used for hot flashes in women, can reduce hot flashes in men with prostate cancer who are on hormone therapy. About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency, severity, and …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
New MRI tech aims to sharpen prostate cancer images
Knowledge-focused Recruiting nowThis study tests new ways to improve MRI scans for prostate cancer. Researchers want to see if better computer methods can make images clearer without needing new equipment. About 1000 adults will join to help compare standard and new image-making techniques. The goal is to impro…
Matched conditions: PROSTATE NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
MRI-Guided radiation: a new era for cancer care?
Knowledge-focused Recruiting nowThis study is collecting information from 8,000 cancer patients treated with a special machine called the MR-Linac, which combines an MRI scanner with a radiation therapy device. The goal is to see how well this technology works for different cancers, including breast, prostate, …
Matched conditions: PROSTATE NEOPLASM
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC